You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 20, May 27, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Cardiology
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (575)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antiatherothrombotic Properties of Statins

Implications for Cardiovascular Event Reduction

Robert S. Rosenson, MD; Christine C. Tangney, PhD

JAMA. 1998;279:1643-1650.

Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or statin therapy have demonstrated that baseline or treated low-density lipoprotein (LDL) cholesterol levels are only weakly associated with net coronary angiographic change or cardiovascular events. The beneficial effects of statins on clinical events may involve nonlipid mechanisms that modify endothelial function, inflammatory responses, plaque stability, and thrombus formation. Experimental animal models suggest that statins may foster stability through a reduction in macrophages and cholesterol ester content and an increase in volume of collagen and smooth muscle cells. The thrombotic sequelae caused by plaque disruption is mitigated by statins through inhibition of platelet aggregation and maintenance of a favorable balance between prothrombotic and fibrinolytic mechanisms. These nonlipid properties of statins may help to explain the early and significant cardiovascular event reduction reported in several clinical trials of statin therapy.


From the Preventive Cardiology Center, Departments of Medicine (Dr Rosenson) and Clinical Nutrition (Dr Tangney), Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Coronary Events With Lipid-Lowering Therapy: The AFCAPS/TexCAPS Trial
I. U. Haq, E. J. Wallis, W. W. Yeo, P. R. Jackson, L. E. Ramsay, Louis H. Krut, David E. Kandzari, Pascal J. Goldschmidt-Clermont, James M. Mason, Nick Freemantle, Todd D. McDiarmid, William A. Hensel, John A. Papadakis, Dimitri P. Mikhailidis, Judith Walsh, David Siegel, Arthur L. M. Swislocki, John R. Downs, Antonio M. Gotto, Jr, Michael Clearfield, Stephen Weis, Robert S. Rosenson, and Christine C. Tangney
JAMA. 1999;281(5):414-419.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
John R. Downs, Michael Clearfield, Stephen Weis, Edwin Whitney, Deborah R. Shapiro, Polly A. Beere, Alexandra Langendorfer, Evan A. Stein, William Kruyer, Antonio M. Gotto, Jr, and for the AFCAPS/TexCAPS Research Group
JAMA. 1998;279(20):1615-1622.
ABSTRACT | FULL TEXT  

Lipid-Lowering Therapy in Low-Risk Patients
Thomas A. Pearson
JAMA. 1998;279(20):1659-1661.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction
Briguori et al.
J Am Coll Cardiol 2009;54:2157-2163.
ABSTRACT | FULL TEXT  

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA)
Authors/Task Force Members et al.
Eur Heart J 2009;30:2769-2812.
FULL TEXT  

American Diabetes Association Indications for Statins in Diabetes: Is there evidence?
Eldor and Raz
Diabetes Care 2009;32:S384-S391.
FULL TEXT  

Statins in Acute Coronary Syndromes: Do the Guideline Recommendations Match the Evidence?
Morrissey et al.
J Am Coll Cardiol 2009;54:1425-1433.
ABSTRACT | FULL TEXT  

Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury
Redecha et al.
Blood 2009;113:4101-4109.
ABSTRACT | FULL TEXT  

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study
Schlitt et al.
J. Lipid Res. 2009;50:723-729.
ABSTRACT | FULL TEXT  

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study
Almroth et al.
Eur Heart J 2009;30:827-833.
ABSTRACT | FULL TEXT  

CD4+CD28null T cells in coronary artery disease: when helpers become killers
Dumitriu et al.
Cardiovasc Res 2009;81:11-19.
ABSTRACT | FULL TEXT  

The impact of statin use on atrial fibrillation
Sanchez-Quinones et al.
QJM 2008;101:845-861.
ABSTRACT | FULL TEXT  

Association of Soluble Cell Adhesion Molecules with Ankle-Brachial Index in a Biethnic Cohort of Predominantly Hypertensive Individuals
Khaleghi et al.
Clin. Chem. 2008;54:1788-1795.
ABSTRACT | FULL TEXT  

HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options
Mallewa et al.
J Antimicrob Chemother 2008;62:648-660.
ABSTRACT | FULL TEXT  

Statins and Interstitial Lung Disease: A Systematic Review of the Literature and of Food and Drug Administration Adverse Event Reports
Fernandez et al.
Chest 2008;134:824-830.
ABSTRACT | FULL TEXT  

Unraveling Pleiotropic Effects Of Statins: Bit By Bit, a Slow Case With Perspective
Arslan et al.
Circ. Res. 2008;103:334-336.
FULL TEXT  

Effect of Pretreatment With Statins on Ischemic Stroke Outcomes
Reeves et al.
Stroke 2008;39:1779-1785.
ABSTRACT | FULL TEXT  

Preprocedural Statin Therapy in Percutaneous Coronary Intervention
Cahoon and Crouch
The Annals of Pharmacotherapy 2007;41:1687-1693.
ABSTRACT | FULL TEXT  

Do statins have an antiarrhythmic activity?
Kostapanos et al.
Cardiovasc Res 2007;75:10-20.
ABSTRACT | FULL TEXT  

Modulation of COX-2 expression by statins in human monocytic cells
Habib et al.
FASEB J. 2007;21:1665-1674.
ABSTRACT | FULL TEXT  

Markers of inflammation are inversely associated with VO2 max in asymptomatic men
Kullo et al.
J. Appl. Physiol. 2007;102:1374-1379.
ABSTRACT | FULL TEXT  

Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy
Yu et al.
Diabetes and Vascular Disease Research 2006;3:189-196.
ABSTRACT  

Direct Demonstration of an Antiinflammatory Effect of Simvastatin in Subjects with the Metabolic Syndrome
Devaraj et al.
J. Clin. Endocrinol. Metab. 2006;91:4489-4496.
ABSTRACT | FULL TEXT  

Sex Difference in the Antiplatelet Effect of Aspirin in Patients with Stroke
Cavallari et al.
The Annals of Pharmacotherapy 2006;40:812-817.
ABSTRACT | FULL TEXT  

Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk
Kumar et al.
Neurology 2006;66:1153-1158.
ABSTRACT | FULL TEXT  

Pitavastatin Effect on ATP Binding Cassette A1-Mediated Lipid Efflux from Macrophages: Evidence for Liver X Receptor (LXR)-Dependent and LXR-Independent Mechanisms of Activation by cAMP
Zanotti et al.
J. Pharmacol. Exp. Ther. 2006;317:395-401.
ABSTRACT | FULL TEXT  

Pravastatin and Clopidogrel Combined Inhibit Intimal Hyperplasia in a Rat Carotid Endarterectomy Model
Bledsoe et al.
VASC ENDOVASCULAR SURG 2006;40:49-57.
ABSTRACT  

Statins and cognitive function in the elderly: The Cardiovascular Health Study
Bernick et al.
Neurology 2005;65:1388-1394.
ABSTRACT | FULL TEXT  

Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
Herman and Moncada
Eur Heart J 2005;26:1945-1955.
ABSTRACT | FULL TEXT  

Intensive lipid lowering with atorvastatin in coronary disease.
Auer et al.
NEJM 2005;353:93-96.
FULL TEXT  

Effects of Cholesterol-Lowering Statins on the Aqueous Humor Outflow Pathway
Song et al.
IOVS 2005;46:2424-2432.
ABSTRACT | FULL TEXT  

Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial
Geluk et al.
Eur Heart J 2005;26:1314-1320.
ABSTRACT | FULL TEXT  

Statin Use and the Risk of Incident Dementia: The Cardiovascular Health Study
Rea et al.
Arch Neurol 2005;62:1047-1051.
ABSTRACT | FULL TEXT  

Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?
Lorenz et al.
Eur Heart J 2005;26:1078-1085.
ABSTRACT | FULL TEXT  

Effect of Different Antilipidemic Agents and Diets on Mortality: A Systematic Review
Studer et al.
Arch Intern Med 2005;165:725-730.
ABSTRACT | FULL TEXT  

Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: The Statins for Risk Reduction in Surgery (StaRRS) study
O'Neil-Callahan et al.
J Am Coll Cardiol 2005;45:336-342.
ABSTRACT | FULL TEXT  

Statins and Blood Coagulation
Undas et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:287-294.
ABSTRACT | FULL TEXT  

Intensive Lipid-Lowering Therapy in Patients with Coronary Heart Disease
Lauderdale and Sheehan
The Annals of Pharmacotherapy 2005;39:329-334.
ABSTRACT | FULL TEXT  

The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome
Prescott et al.
The Annals of Pharmacotherapy 2004;38:2105-2114.
ABSTRACT | FULL TEXT  

Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis
Amarenco et al.
Stroke 2004;35:2902-2909.
ABSTRACT | FULL TEXT  

Early Withdrawal of Statin Therapy in Patients With Non-ST-Segment Elevation Myocardial Infarction: National Registry of Myocardial Infarction
Spencer et al.
Arch Intern Med 2004;164:2162-2168.
ABSTRACT | FULL TEXT  

Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep
Zhou et al.
Blood 2004;104:2353-2358.
ABSTRACT | FULL TEXT  

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction
Briguori et al.
Eur Heart J 2004;25:1822-1828.
ABSTRACT | FULL TEXT  

Role of Endothelial Dysfunction in Atherosclerosis
Davignon and Ganz
Circulation 2004;109:III-27-III-32.
ABSTRACT | FULL TEXT  

Statins for Stroke Prevention: Disappointment and Hope
Amarenco and Tonkin
Circulation 2004;109:III-44-III-49.
ABSTRACT | FULL TEXT  

Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study
Spencer et al.
ANN INTERN MED 2004;140:857-866.
ABSTRACT | FULL TEXT  

Coronary Event Secondary Prevention with Statins Irrespective of LDL-Cholesterol
Kerst and Mauro
The Annals of Pharmacotherapy 2004;38:1060-1064.
ABSTRACT | FULL TEXT  

Cholesterol Is Associated With Stroke, but Is Not a Risk Factor
Thrift
Stroke 2004;35:1524-1525.
FULL TEXT  

Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses?
Watts
Eur Heart J 2004;25:716-719.
FULL TEXT  

Protective Role of Imatinib in Atherosclerosis
Kadowaki and Kubota
Arterioscler. Thromb. Vasc. Bio. 2004;24:801-803.
FULL TEXT  

Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Marti-Fabregas et al.
Stroke 2004;35:1117-1121.
ABSTRACT | FULL TEXT  

Lipid Control in the Management of Type 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians
Snow et al.
ANN INTERN MED 2004;140:644-649.
ABSTRACT | FULL TEXT  

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure
Horwich et al.
J Am Coll Cardiol 2004;43:642-648.
ABSTRACT | FULL TEXT  

Pitavastatin Downregulates Expression of the Macrophage Type B Scavenger Receptor, CD36
Han et al.
Circulation 2004;109:790-796.
ABSTRACT | FULL TEXT  

Commentary: Development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding'
Tobin et al.
Int J Epidemiol 2004;33:26-29.
FULL TEXT  

Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy
Li et al.
Am. J. Physiol. Renal Physiol. 2004;286:F46-F57.
ABSTRACT | FULL TEXT  

Cholesterol and the Risk of Ischemic Stroke
Bowman et al.
Stroke 2003;34:2930-2934.
ABSTRACT | FULL TEXT  

Primary Prevention of Coronary Heart Disease in the Elderly
Dornbrook-Lavender et al.
The Annals of Pharmacotherapy 2003;37:1654-1663.
ABSTRACT | FULL TEXT  

Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models
Susic et al.
J Am Coll Cardiol 2003;42:1091-1097.
ABSTRACT | FULL TEXT  

Genetic and Acquired Determinants of Individual Variability of Response to Antiplatelet Drugs
Schafer
Circulation 2003;108:910-911.
FULL TEXT  

Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: Coronary artery disease regression single photon emission computed tomography monitoring trial
Schwartz et al.
J Am Coll Cardiol 2003;42:600-610.
ABSTRACT | FULL TEXT  

Hemostatic Effects of Atorvastatin Versus Simvastatin
Kadikoylu et al.
The Annals of Pharmacotherapy 2003;37:478-484.
ABSTRACT | FULL TEXT  

Differential Effects of Lipid-Lowering Therapies on Stroke Prevention: A Meta-analysis of Randomized Trials
Corvol et al.
Arch Intern Med 2003;163:669-676.
ABSTRACT | FULL TEXT  

Statin effects beyond lipid lowering--are they clinically relevant?
Bonetti et al.
Eur Heart J 2003;24:225-248.
FULL TEXT  

Estrogen and Stroke: A Balanced Analysis
Hurn and Brass
Stroke 2003;34:338-341.
FULL TEXT  

Fluvastatin Prevents Renal Dysfunction and Vascular NO Deficit in Apolipoprotein E-Deficient Mice
Gervais et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:183-189.
ABSTRACT | FULL TEXT  

Statin Therapy Interacts With Cytomegalovirus Seropositivity and High C-Reactive Protein in Reducing Mortality Among Patients With Angiographically Significant Coronary Disease
Horne et al.
Circulation 2003;107:258-263.
ABSTRACT | FULL TEXT  

Statins and stroke: evidence for cholesterol-independent effects
Di Napoli et al.
Eur Heart J 2002;23:1908-1921.
 

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial
Liem et al.
Eur Heart J 2002;23:1931-1937.
ABSTRACT  

Atherogenesis--recent insights into basic mechanisms and their clinical impact
Schachinger and Zeiher
Nephrol Dial Transplant 2002;17:2055-2064.
FULL TEXT  

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-a reductase inhibitor treatment, and progression of aortic stenosis in the community
Bellamy et al.
J Am Coll Cardiol 2002;40:1723-1730.
ABSTRACT | FULL TEXT  

Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival
Mehra et al.
J Am Coll Cardiol 2002;40:1609-1614.
ABSTRACT | FULL TEXT  

Unraveling Pleiotropic Effects of Statins on Plaque Rupture
Palinski and Napoli
Arterioscler. Thromb. Vasc. Bio. 2002;22:1745-1750.
FULL TEXT  

Low-Density Lipoprotein Lowering and Atherosclerosis Progression: Does More Mean Less?
Shah
Circulation 2002;106:2039-2040.
FULL TEXT  

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness
Taylor et al.
Circulation 2002;106:2055-2060.
ABSTRACT | FULL TEXT  

Statin Lipid-Lowering Therapy for Acute Myocardial Infarction and Unstable Angina: Efficacy and Mechanism of Benefit
Wright et al.
Mayo Clin Proc. 2002;77:1085-1092.
ABSTRACT  

Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis
Fonarow
Vasc Med 2002;7:187-194.
ABSTRACT  

Regulatory Effects of HMG CoA Reductase Inhibitor and Fish Oils on Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Male Subjects With Dyslipidemia
Chan et al.
Diabetes 2002;51:2377-2386.
ABSTRACT | FULL TEXT  

Cholesterol Predicts Stroke Mortality in the Women's Pooling Project
Horenstein et al.
Stroke 2002;33:1863-1868.
ABSTRACT | FULL TEXT  

Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)
Herrington et al.
Circulation 2002;105:2962-2967.
ABSTRACT | FULL TEXT  

Therapy With Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors (Statins) and Associated Risk of Incident Cardiovascular Events in Older Adults: Evidence From the Cardiovascular Health Study
Lemaitre et al.
Arch Intern Med 2002;162:1395-1400.
ABSTRACT | FULL TEXT  

Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease
Franz Alber et al.
J Am Coll Cardiol 2002;39:1951-1955.
ABSTRACT | FULL TEXT  

Early Statin Initiation and Outcomes in Patients With Acute Coronary Syndromes
Newby et al.
JAMA 2002;287:3087-3095.
ABSTRACT | FULL TEXT  

Reducing cholesterol and atherosclerosis
Hornung
QJM 2002;95:339-341.
FULL TEXT  

Effect of Atorvastatin and Fish Oil on Plasma High-Sensitivity C-Reactive Protein Concentrations in Individuals with Visceral Obesity
Chan et al.
Clin. Chem. 2002;48:877-883.
ABSTRACT | FULL TEXT  

Immunomodulatory Effects of Statins: Mechanisms and Potential Impact on Arteriosclerosis
Palinski and Tsimikas
J. Am. Soc. Nephrol. 2002;13:1673-1681.
ABSTRACT | FULL TEXT  

Reversal of Thrombin-Induced Deactivation of CD39/ATPDase in Endothelial Cells by HMG-CoA Reductase Inhibition: Effects on Rho-GTPase and Adenosine Nucleotide Metabolism
Kaneider et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:894-900.
ABSTRACT | FULL TEXT  

Rho-GTPase-Dependent Platelet-Neutrophil Interaction Affected by HMG-CoA Reductase Inhibition With Altered Adenosine Nucleotide Release and Function
Kaneider et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1029-1035.
ABSTRACT | FULL TEXT  

Statins and chronic heart failure: do we need a large-scale outcome trial?
Krum and McMurray
J Am Coll Cardiol 2002;39:1567-1573.
ABSTRACT | FULL TEXT  

Short-term effects of atorvastatin on C-reactive protein
Riesen et al.
Eur Heart J 2002;23:794-799.
ABSTRACT | FULL TEXT  

Pleiotropic Effects of Statins: Lipid Reduction and Beyond
McFarlane et al.
J. Clin. Endocrinol. Metab. 2002;87:1451-1458.
ABSTRACT | FULL TEXT  

Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering
Baetta et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:692-698.
ABSTRACT | FULL TEXT  

Lipid lowering and the assessment of endothelial function
Lee et al.
Cardiovasc Res 2002;54:191-192.
FULL TEXT  

Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women
Yaffe et al.
Arch Neurol 2002;59:378-384.
ABSTRACT | FULL TEXT  

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT | FULL TEXT  

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project
Simes et al.
Eur Heart J 2002;23:207-215.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.